Skip to content

Rescue Effect of TEAS on PONV after Prophylactic Use of Palonosetron and Dexamethasone in High-risk Patients: A Randomized Controlled Trial

Rescue Effect of Transcutaneous Electrical Acupoint Stimulation on Failed Postoperative Nausea and Vomiting Prophylaxis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080135
Enrollment
Unknown
Registered
2024-01-22
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting

Interventions

TEAS groups:Select the HANS-200A transcutaneous nerve electrical stimulator (batch number: 200110514089), paste electrode sheets on the patients Nei Guan point and Hegu point and turn on the electroac
Sham Group:The electrodes were pasted on Neiguan and Hegu points without opening the electroacupuncture stimulation. Patients were informed prior to intervention that therapeutic stimuli might not be

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. A well-diagnosed patient who requires elective surgery; 2. age = 18 years; 3. American College of Anesthesiologists (ASA) ? to ?; 4. Apfel simplified risk score is high risk (score =3); 5.No significant organ dysfunction; 6.electrocardiogram is normal and hemodynamic is stable.

Exclusion criteria

Exclusion criteria: 1. Application of pacemakers; 2. Pregnant patients; 3. Difficulties in language or communication; 4. A past history of central nervous system disease or mental illness or a speech disorder; 5. Use glucocorticoid, opioids or anti-emetics 24 hours before surgery; 6. Receive acupuncture therapy within 2 weeks. 7. The skin of acupuncture site is damaged or infected; 8. Severe Heart, lung, liver and kidney dysfunction; 9. Nerve damage in the upper or lower extremities; 10. Preoperative pain, use of central analgesics, or opioid addiction, dependence; 11. Participated in other clinical trials within the last four weeks.

Design outcomes

Primary

MeasureTime frame
complete response rate;

Secondary

MeasureTime frame
The use of antiemetic drugs;Time from treatment to recovery;VAS pain score;Maximum nausea score;Painkiller use;PACU stay time;Length of patient stay;Hospitalization expenses;Quality of Recovery-40 questionnaire score;Patient satisfaction;

Countries

China

Contacts

Public ContactMo Yunchang

The first hospital affiliated to wenzhou medical college

myc1104@163.com+86 137 3692 4260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026